Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

BNGO holding history

Bionano Genomics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BNGO overviewAll 13F holders of BNGOFull Q4 2025 holdings

Shares (Q4 2025)
82,307
Value
$125.9K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of BNGO by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 202582,307$125.9K<0.1%+31,848+63.1%AddedHolders
Q3 202550,459$86.3K<0.1%+50,459NewHolders
Q2 20250$00.0%−49,979−100.0%Sold outHolders
Q1 202549,979$139.4K<0.1%−1,830,144−97.3%ReducedHolders
Q4 20241,880,123$541.5K<0.1%−312,369−14.2%ReducedHolders
Q3 20242,192,492$995.4K<0.1%+102,495+4.9%AddedHolders
Q2 20242,089,997$1.42M<0.1%+195,236+10.3%AddedHolders
Q1 20241,894,761$2.10M<0.1%+1,116+0.1%AddedHolders
Q4 20231,893,645$3.58M<0.1%+400,022+26.8%AddedHolders
Q3 20231,493,623$4.53M<0.1%+41,930+2.9%AddedConverted for a 1-for-10 splitHolders
Q2 202314,516,927$8.86M<0.1%−1,894,016−11.5%ReducedHolders
Q1 202316,410,943$18.2M<0.1%+346,499+2.2%AddedHolders
Q4 202216,064,444$23.5M<0.1%+319,715+2.0%AddedHolders
Q3 202215,744,729$28.8M<0.1%+110,332+0.7%AddedHolders
Q2 202215,634,397$21.6M<0.1%−241,892−1.5%ReducedHolders
Q1 202215,876,289$41.0M<0.1%+1,050,655+7.1%AddedHolders
Q4 202114,825,634$44.3M<0.1%−227,638−1.5%ReducedHolders
Q3 202115,053,272$82.8M<0.1%+197,836+1.3%AddedHolders
Q2 202114,855,436$108.9M<0.1%+5,559,597+59.8%AddedHolders
Q1 20219,295,839$75.1M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.